QIR Suite vs Reveal LINQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CASIS Cardiac Simulation & Imaging Software
VS
by Medtronic

AI Verdict

Tool A, QIR Suite, is an AI-powered software designed for quantitative analysis of cardiovascular MR and CT images, focusing on structural and functional assessment. In contrast, Tool B, Reveal LINQ, is an implantable cardiac monitor that uses AI to continuously record ECG data for the detection and diagnosis of cardiac arrhythmias. While both leverage AI in cardiology, they address different diagnostic needs through distinct modalities: imaging analysis versus continuous rhythm monitoring.

Choose QIR Suite if…

Choose QIR Suite if your primary need is a comprehensive, AI-powered quantitative analysis of cardiac MR and CT images to support diagnosis and prognosis. This tool is ideal for clinicians requiring detailed measurements of heart regions, pathological areas, blood flow, and strain from existing imaging data. It excels in providing in-depth structural and functional insights for various cardiovascular conditions.

View QIR Suite →

Choose Reveal LINQ if…

Choose Reveal LINQ if you require long-term, continuous cardiac rhythm monitoring for patients experiencing infrequent or suspected arrhythmias, unexplained syncope, or cryptogenic stroke. This implantable device is best suited for detecting elusive cardiac events over an extended period (up to three years), leveraging AI algorithms to accurately identify conditions like atrial fibrillation that might otherwise be missed by shorter-term monitoring.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature QIR Suite Reveal LINQ
Pricing Contact for pricing Unknown
Deployment Locally on dedicated hardware The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Reveal LINQ

Reveal LINQ (Tool B) offers superior usability due to its passive, continuous monitoring for patients after a minimally invasive insertion, and a convenient mobile app for clinicians to manage data. QIR Suite (Tool A), while described as intuitive for specialists, requires active interaction with software on dedicated hardware, which is a more demanding workflow.

Clinical Value

Reveal LINQ

Reveal LINQ (Tool B) provides significant clinical value through its long-term (up to three years) continuous ECG monitoring and AccuRhythmu2122 AI algorithms, which accurately detect and diagnose elusive cardiac arrhythmias while reducing false alerts by 85%. This directly improves diagnostic yield and clinician efficiency. QIR Suite (Tool A) offers detailed quantitative imaging analysis, but Reveal LINQ's ability to capture transient, critical events over an extended period addresses a distinct and high-impact clinical need.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing, offering no public transparency. Their pricing models are fundamentally different u2013 a software license/subscription for QIR Suite (Tool A) versus an implantable medical device typically integrated into procedure costs for Reveal LINQ (Tool B). Without specific cost data, a direct comparison of value is not possible.

Enterprise Readiness

Reveal LINQ

Reveal LINQ (Tool B), from Medtronic, explicitly states HIPAA compliance for its associated apps and acknowledges its HIPAA obligations for customers, backed by comprehensive privacy principles. Its deployment integrates with a robust CareLinku2122 network and mobile app. While QIR Suite (Tool A) has international regulatory clearances (FDA, CE, ISO 13485) and PACS/HL7 integration, Medtronic's explicit commitment to HIPAA and its established global infrastructure indicate a higher level of enterprise readiness.

Innovation

Reveal LINQ

Reveal LINQ (Tool B) demonstrates superior innovation as the world's smallest insertable cardiac monitor, offering continuous ECG monitoring for up to three years with groundbreaking AccuRhythmu2122 AI algorithms that significantly reduce false alerts. Its MRI compatibility without a post-insertion waiting period further highlights its innovative design. While QIR Suite (Tool A) uses advanced AI for imaging analysis, Reveal LINQ's combination of miniaturization, longevity, and intelligent false alert reduction is a more transformative advancement in its field.

Support & Docs

Reveal LINQ

As a product of Medtronic, a global leader in medical technology, Reveal LINQ (Tool B) benefits from extensive institutional support, training, and comprehensive documentation, which are critical for implantable medical devices. QIR Suite (Tool A) does not provide explicit details regarding its support or documentation offerings, making it difficult to assess its capabilities in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature QIR Suite Reveal LINQ
Name QIR Suite Reveal LINQ
Company CASIS Cardiac Simulation & Imaging Software Medtronic
Description AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis. Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.
Key Features AI-based analysis of MR and CT examinations; Detection of heart regions and pathological areas; Quantification of over 100 clinical parameters; Automatic segmentation; Blood flow/velocities quantification; Pathological volumes detection and quantification; Semi-quantification of myocardial perfusion; Strain quantification World's smallest insertable cardiac monitor (1.2 mL); Continuous ECG monitoring for up to three years; AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause); Automatic and patient-activated event recording; MRI Conditional (1.5T and 3T) with no post-insertion waiting; Minimally invasive, simplified insertion procedure; Wireless data transmission to CareLinku2122 network via MyCareLinku2122 Patient Monitor; Reveal LINQu2122 Mobile Manager app for clinician device management
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Radiology Cardiology, Neurology

Videos

Demos, reviews, and walkthroughs featuring QIR Suite and Reveal LINQ.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

QIR Suite is an AI-based software that analyzes MR and CT images to provide quantitative evaluations for diagnosing and prognosticating cardiovascular conditions. In contrast, Reveal LINQ is an implantable cardiac monitor that continuously records ECG for up to three years to detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.
QIR Suite employs AI for the analysis of MR and CT examinations, including the detection of heart regions, pathological areas, and the quantification of over 100 clinical parameters, as well as automatic segmentation and strain quantification. Reveal LINQ integrates AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias and significantly reduce false alerts for conditions like atrial fibrillation and pauses.
QIR Suite provides quantitative data from MR and CT images, such as automatic segmentation, blood flow/velocities, pathological volumes, semi-quantification of myocardial perfusion, and strain quantification. Reveal LINQ offers continuous ECG recordings over an extended period, identifying and diagnosing cardiac arrhythmias, with automatic and patient-activated event recording capabilities.
QIR Suite focuses on supporting the diagnosis and prognosis of a broad range of cardiovascular conditions through the quantitative evaluation of structural and functional aspects from MR and CT images. Reveal LINQ is specifically designed for the detection and diagnosis of cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope, through continuous ECG monitoring.
AI Tool Finder
AI-powered search. Results may not be comprehensive.